oldlillycoi.wordpress.com
Increasing Minority Participation in Cancer Clinical Trials
Failing to recruit a diverse population of patients for clinical trials can have a negative impact on drug research. Last year, Lilly CEO John Lechleiter pointed out in a Forbes editorial that &#82…